Michael McGrath
Corporate Officer/Principal at The University of California, San Francisco
Michael McGrath active positions
| Companies | Position | Start | End |
|---|---|---|---|
| The University of California, San Francisco | Corporate Officer/Principal | 22/03/2010 | - |
Career history of Michael McGrath
Former positions of Michael McGrath
| Companies | Position | Start | End |
|---|---|---|---|
Neuraltus Pharmaceuticals, Inc.
 Neuraltus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Neuraltus Pharmaceuticals, Inc. develops and commercializes molecule therapeutics. It engages in the development of therapeutics to treat neurodegenerative diseases including amyotrophic lateral sclerosis (ALS), Parkinson's disease, and Alzheimer's disease as well as inherited metaboloic disorders such as Fabry's disease and Gaucher's disease which also result in neuronal cell death. The company was founded by Michael McGrath, Edgar G. Engleman, and Ari Azhir in 2004 and is headquartered in San Bruno, CA. | Chief Tech/Sci/R&D Officer | 01/01/2004 | - |
| Founder | 01/01/2004 | - |
Statistics
International
| United States | 3 |
Operational
| Chief Tech/Sci/R&D Officer | 1 |
| Founder | 1 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 1 |
|---|---|
Neuraltus Pharmaceuticals, Inc.
Neuraltus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Neuraltus Pharmaceuticals, Inc. develops and commercializes molecule therapeutics. It engages in the development of therapeutics to treat neurodegenerative diseases including amyotrophic lateral sclerosis (ALS), Parkinson's disease, and Alzheimer's disease as well as inherited metaboloic disorders such as Fabry's disease and Gaucher's disease which also result in neuronal cell death. The company was founded by Michael McGrath, Edgar G. Engleman, and Ari Azhir in 2004 and is headquartered in San Bruno, CA. | Health Technology |
- Stock Market
- Insiders
- Michael McGrath
- Experience
